| Year |
Citation |
Score |
| 2023 |
Sarayani A, Brown JD, Hampp C, Donahoo WT, Winterstein AG. Adaptability of High Dimensional Propensity Score Procedure in the Transition from ICD-9 to ICD-10 in the US Healthcare System. Clinical Epidemiology. 15: 645-660. PMID 37274833 DOI: 10.2147/CLEP.S405165 |
0.583 |
|
| 2023 |
Sarayani A, Donahoo WT, Hampp C, Brown JD, Winterstein AG. Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine-Topiramate to Prevent Exposure During Pregnancy. Annals of Internal Medicine. PMID 36940443 DOI: 10.7326/M22-1743 |
0.622 |
|
| 2022 |
Sarayani A, Hampp C, Brown JD, Donahoo WT, Winterstein AG. Topiramate Utilization After Phentermine/Topiramate Approval for Obesity Management: Risk Minimization in the Era of Drug Repurposing. Drug Safety. PMID 36318419 DOI: 10.1007/s40264-022-01244-6 |
0.624 |
|
| 2021 |
Pottegård A, Morin L, Hallas J, Gerhard T, Winterstein AG, Perez-Gutthann S, Tadrous M. Where to begin? Thirty must-read papers for newcomers to pharmacoepidemiology. Pharmacoepidemiology and Drug Safety. PMID 34738294 DOI: 10.1002/pds.5382 |
0.498 |
|
| 2021 |
Choi Y, Meissner HC, Hampp C, Park H, Winterstein AG. Utilization of chronic lung disease treatment before the respiratory syncytial virus season as palivizumab prophylaxis qualifier in the American Academy of Pediatrics Guidelines. European Journal of Pediatrics. PMID 34365543 DOI: 10.1007/s00431-021-04233-6 |
0.636 |
|
| 2020 |
Choi Y, Meissner HC, Hampp C, Park H, Brumback B, Winterstein AG. Calibration of Chronic Lung Disease Severity as a Risk Factor for Respiratory Syncytial Virus Hospitalization. Journal of the Pediatric Infectious Diseases Society. PMID 32978942 DOI: 10.1093/jpids/piaa107 |
0.655 |
|
| 2020 |
Zhu Y, Hampp C, Wang X, Albogami Y, Wei YJ, Brumback BA, Roussos-Ross D, Winterstein AG. Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract-Quantifying the misclassification of maternal drug exposure during pregnancy. Pharmacoepidemiology and Drug Safety. PMID 32909348 DOI: 10.1002/Pds.5126 |
0.6 |
|
| 2020 |
Winterstein AG, Li Y, Gerhard T, Linden S, Shuster JJ. Medication Use for ADHD and the Risk of Driving Citations and Crashes Among Teenage Drivers: A Population-Based Cohort Study. Journal of Attention Disorders. 1087054720915768. PMID 32338114 DOI: 10.1177/1087054720915768 |
0.598 |
|
| 2020 |
Jugl S, Keshwani S, Adkins L, Heldermon CD, Winterstein A, Goodin A. A systematic review of evidence for cannabis and cannabinoids as adjuvant therapy in palliative and supportive oncology care. Journal of Clinical Oncology. 38: 12091-12091. DOI: 10.1200/Jco.2020.38.15_Suppl.12091 |
0.308 |
|
| 2019 |
Choi Y, Park H, Hampp C, Brumback B, Meissner HC, Li Y, Roussos-Ross D, Zhu Y, Henriksen C, Winterstein AG. Usability of encounter data for Medicaid comprehensive managed care vs traditional Medicaid fee-for-service claims among pregnant women. Pharmacoepidemiology and Drug Safety. PMID 31737976 DOI: 10.1002/Pds.4923 |
0.601 |
|
| 2019 |
Knox CA, Hampp C, Palmsten K, Zhu Y, Setoguchi S, Brumback B, Segal R, Winterstein AG. Validation of mother-infant linkage using Medicaid Case ID variable within the Medicaid Analytic eXtract (MAX) database. Pharmacoepidemiology and Drug Safety. PMID 31286606 DOI: 10.1002/Pds.4843 |
0.597 |
|
| 2018 |
Liu W, Antonelli PJ, Dahm P, Gerhard T, Delaney JAC, Segal R, Crystal S, Winterstein AG. Risk of sudden sensorineural hearing loss in adults using phosphodiesterase type 5 inhibitors: Population-based cohort study. Pharmacoepidemiology and Drug Safety. PMID 29512263 DOI: 10.1002/Pds.4405 |
0.546 |
|
| 2017 |
Winterstein AG, Soria-Saucedo R, Gerhard T, Correll CU, Olfson M. Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers. The Journal of Clinical Psychiatry. PMID 28686819 DOI: 10.4088/JCP.16m10884 |
0.576 |
|
| 2016 |
Linden S, Bussing R, Kubilis P, Gerhard T, Segal R, Shuster JJ, Winterstein AG. Risk of Suicidal Events With Atomoxetine Compared to Stimulant Treatment: A Cohort Study. Pediatrics. 137. PMID 27244795 DOI: 10.1542/Peds.2015-3199 |
0.579 |
|
| 2016 |
Zambrano D, Winterstein A, Bussing R, Yang S, Pace K, Campbell K. Risk factors for hospital readmission of psychiatric patients: a systematic literature review Research in Social and Administrative Pharmacy. 12: e9. DOI: 10.1016/J.Sapharm.2016.05.024 |
0.328 |
|
| 2015 |
Knox C, Hampp C, Willy M, Winterstein AG, Dal Pan G. Patient understanding of drug risks: an evaluation of medication guide assessments. Pharmacoepidemiology and Drug Safety. 24: 518-25. PMID 25808393 DOI: 10.1002/Pds.3762 |
0.641 |
|
| 2015 |
Knox C, Hampp C, Willy M, Winterstein AG, Pan GD. Patient understanding of drug risks: An evaluation of medication guide assessments Pharmacoepidemiology and Drug Safety. 24: 518-525. DOI: 10.1002/pds.3762 |
0.645 |
|
| 2014 |
Toteja N, Gallego JA, Saito E, Gerhard T, Winterstein A, Olfson M, Correll CU. Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment International Journal of Neuropsychopharmacology. 17: 1095-1105. PMID 23673334 DOI: 10.1017/S1461145712001320 |
0.607 |
|
| 2013 |
Winterstein AG, Knox CA, Kubilis P, Hampp C. Appropriateness of age thresholds for respiratory syncytial virus immunoprophylaxis in moderate-preterm infants a cohort study Jama Pediatrics. 167: 1118-1124. PMID 24126903 DOI: 10.1001/Jamapediatrics.2013.2636 |
0.642 |
|
| 2013 |
Birnbaum ML, Saito E, Gerhard T, Winterstein A, Olfson M, Kane JM, Correll CU. Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implications. Current Psychiatry Reports. 15: 382. PMID 23881713 DOI: 10.1007/S11920-013-0382-3 |
0.587 |
|
| 2013 |
Hampp C, Asal N, Lipowski E, Kauf T, Schneider E, Kubilis P, Winterstein A. Validity of laboratory-based surveillance for detection of respiratory syncytial virus seasons American Journal of Epidemiology. 177: 841-851. PMID 23479344 DOI: 10.1093/Aje/Kws304 |
0.689 |
|
| 2012 |
Hampp C, Kauf TL, Saidi AS, Winterstein AG. Methodological Concerns Regarding Cost-effectiveness Analysis of Palivizumab in Florida Medicaid-Reply. Archives of Pediatrics & Adolescent Medicine. 166: 968-70. PMID 23753905 DOI: 10.1001/Archpediatrics.2012.1594 |
0.603 |
|
| 2012 |
Gerhard T, Delaney JA, Cooper-Dehoff RM, Shuster J, Brumback BA, Johnson JA, Pepine CJ, Winterstein AG. Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy. Bmc Medical Research Methodology. 12: 119. PMID 22866767 DOI: 10.1186/1471-2288-12-119 |
0.516 |
|
| 2012 |
Winterstein AG, Gerhard T, Kubilis P, Saidi A, Linden S, Crystal S, Zito J, Shuster JJ, Olfson M. Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study. Bmj (Clinical Research Ed.). 345: e4627. PMID 22809800 DOI: 10.1136/Bmj.E4627 |
0.547 |
|
| 2012 |
Eworuke E, Hampp C, Saidi A, Winterstein AG. An algorithm to identify preterm infants in administrative claims data Pharmacoepidemiology and Drug Safety. 21: 640-650. PMID 22504840 DOI: 10.1002/Pds.3264 |
0.621 |
|
| 2012 |
Olfson M, Huang C, Gerhard T, Winterstein AG, Crystal S, Allison PD, Marcus SC. Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 51: 147-56. PMID 22265361 DOI: 10.1016/J.Jaac.2011.11.008 |
0.574 |
|
| 2012 |
Winterstein AG, Hampp C, Saidi A. Effectiveness of palivizumab prophylaxis in infants and children in Florida Pharmacoepidemiology and Drug Safety. 21: 53-60. PMID 21919115 DOI: 10.1002/Pds.2246 |
0.654 |
|
| 2012 |
Hampp C, Kauf TL, Saidi AS, Winterstein AG. In reply Archives of Pediatrics and Adolescent Medicine. 166: 969-970. DOI: 10.1001/archpediatrics.2012.1594 |
0.569 |
|
| 2011 |
Hampp C, Kauf TL, Saidi AS, Winterstein AG. Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications Archives of Pediatrics and Adolescent Medicine. 165: 498-505. PMID 21300647 DOI: 10.1001/Archpediatrics.2010.298 |
0.655 |
|
| 2010 |
Hampp C, Kauf TL, Winterstein AG. Small budget impact is a result of flawed assumptions and ignores questionable cost-effectiveness for RSV prophylaxis Value in Health. 13: 684. PMID 20412545 DOI: 10.1111/J.1524-4733.2010.00723.X |
0.665 |
|
| 2010 |
Gerhard T, Winterstein AG, Olfson M, Huang C, Saidi A, Crystal S. Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD. Pharmacoepidemiology and Drug Safety. 19: 457-64. PMID 20232490 DOI: 10.1002/Pds.1931 |
0.547 |
|
| 2010 |
Hampp C, Saidi AS, Winterstein AG. Palivizumab Utilization and Compliance: Trends in Respiratory Syncytial Virus Prophylaxis in Florida Journal of Pediatrics. 156. PMID 20223478 DOI: 10.1016/J.Jpeds.2009.12.016 |
0.642 |
|
| 2009 |
Winterstein AG, Gerhard T, Shuster J, Saidi A. Cardiac Safety of Methylphenidate Versus Amphetamine Salts in the Treatment of ADHD Pediatrics. 124. PMID 19564272 DOI: 10.1542/Peds.2008-3138 |
0.601 |
|
| 2009 |
Chen CY, Gerhard T, Winterstein AG. Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology. 19: 187-95. PMID 19364296 DOI: 10.1089/Cap.2008.096 |
0.548 |
|
| 2009 |
Hampp C, Kauf T, Saidi A, Winterstein A. PRS17 COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS WITH PALIVIZUMAB FROM THE PERSPECTIVE OF A SOUTHERN US MEDICAID AGENCY Value in Health. 12: A301-A302. DOI: 10.1016/S1098-3015(10)74479-X |
0.636 |
|
| 2008 |
Hampp C, Winterstein AG. Response to respiratory synctial virus Southern Medical Journal. 101. PMID 18364631 DOI: 10.1097/Smj.0B013E3181611D5F |
0.591 |
|
| 2008 |
Onyenwenyi AJ, Winterstein AG, Hatton RC. An evaluation of the effects of gatifloxacin on glucose homeostasis Pharmacy World and Science. 30: 544-549. PMID 18297409 DOI: 10.1007/S11096-008-9205-8 |
0.76 |
|
| 2008 |
Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database Annals of Pharmacotherapy. 42: 24-31. PMID 18042808 DOI: 10.1345/Aph.1K143 |
0.584 |
|
| 2007 |
Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics. 120: e1494-501. PMID 18055666 DOI: 10.1542/Peds.2007-0675 |
0.573 |
|
| 2006 |
Gerhard T, Zineh I, Winterstein AG, Hartzema AG. Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure Pharmacotherapy. 26: 34-43. PMID 16509026 DOI: 10.1592/Phco.2006.26.1.34 |
0.553 |
|
| 2006 |
Beaver TM, Winterstein AG, Shuster JJ, Gerhard T, Martin T, Alexander JA, Johnson RJ, Ejaz A, Hartzema AG. Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery. Clinical Cardiology. 29: 18-24. PMID 16477773 DOI: 10.1002/clc.4960290106 |
0.521 |
|
| 2006 |
Gabrielli A, Sungur M, Layon J, Bihorac A, Tyler AM, Winterstein AG, LeClaire A, Onyenwenyi A, Staley B. INAPPROPRIATE USE OF VANCOMYCIN IN CRITICALLY ILL PATIENTS WITH AKI. Critical Care Medicine. 34: A137. DOI: 10.1097/00003246-200612002-00474 |
0.734 |
|
| 2006 |
Winterstein AG, Gerhard T, Shuster J, Li J, Garman P, Linden S, Liu H, Johnson M. Incidence and Prevalence of Central Nervous System Stimulant (CNSS) Use in Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD): A Study of Florida Medicaid Beneficiaries 1994-2004 American Journal of Epidemiology. 163: S36-S36. DOI: 10.1093/Aje/163.Suppl_11.S36-C |
0.567 |
|
| 2006 |
Gerhard T, Winterstein AG, Shuster J, Li J, Garman P, Linden S, Johnson M. Demographic Differences in Central Nervous System Stimulant (CNSS) Use in Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD): A Study of Florida Medicaid Beneficiaries 1994-2004 American Journal of Epidemiology. 163: S35-S35. DOI: 10.1093/Aje/163.Suppl_11.S35-C |
0.565 |
|
| 2004 |
Winterstein AG, Johns TE, Rosenberg EI, Hatton RC, Gonzalez-Rothi R, Kanjanarat P. Nature and causes of clinically significant medication errors in a tertiary care hospital American Journal of Health-System Pharmacy. 61: 1908-1916. PMID 15487880 DOI: 10.1093/Ajhp/61.18.1908 |
0.712 |
|
| 2003 |
Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, Segal R. Nature of preventable adverse drug events in hospitals: a literature review. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 60: 1750-9. PMID 14503111 DOI: 10.1093/Ajhp/60.17.1750 |
0.72 |
|
| Show low-probability matches. |